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Abstract 
The association between maternal smoking and preterm birth (PTB) has been known for more 
than 50 years but the effect of passive smoking is controversial. This retrospective cohort study in 
Bristol, UK, examines the effect of environmental tobacco smoke exposure (ETSE) on gestational age 
at delivery, birth weight, PTB and small-for-gestational age (SGA). ETSE was defined by either self-
report or exhaled carbon monoxide (eCO) levels; exposed women were compared with unexposed 
controls. Two models were used: The first included all women with adjustment for maternal 
smoking, the second considered non-smokers alone. Both models were further adjusted for 
maternal age, BMI, parity, ethnicity, employment status, socioeconomic position, asthma, pre-
eclampsia and offspring sex. Logistic regression and likelihood ratio tests were used to test for any 
association between exposure and the binary outcomes (PTB and SGA), whilst linear regression and 
F-tests were used to test for associations between exposure and the continuous outcomes. There 
were 13359 deliveries in 2012-2014, with complete data for 5066 and 4793 women in the self-
reported and eCO-measured exposure groups, respectively. Self-reported exposure was associated 
with earlier delivery (-0.19 weeks; 95% CI: -0.32 to -0.05) and reduced birth weight (-56 g, 95% CI: -
97 to -16 g) but no increase in the risk of PTB or SGA.  There was no evidence for an association 
between eCO-measured exposure and any of the outcome measures. This information is important 
when advising women and their families, and adds further support to continued public health efforts 
to reduce exposure to tobacco smoke. 
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Introduction 
The association between maternal smoking,  reduced birth weight and preterm birth (PTB) has 
been known for  more than 50 years1. Maternal smoking increases the risk of PTB by around 27%2 
and a dose-response relationship has been described in which heavier smoking is associated with a 
higher risk2,3. Proposed mechanisms for the adverse perinatal outcomes include reduced fetal 
oxygenation secondary to increased carbon monoxide and nicotine-induced vasoconstriction4. 
Previous studies have demonstrated the deleterious effect of active smoking during pregnancy, but 
the extent of the effects of passive smoking is still uncertain5-7. Complications related to prematurity  
account for more than one million deaths each year worldwide 8. The survivors often face severe 
morbidity into childhood and beyond9. There are serious negative psychosocial and emotional 
effects on the family and important resource implications for society9. Preterm birth is the leading 
cause of perinatal mortality and morbidity and its prevention is a global priority8.  
Cigarette smoking during pregnancy is one of the few preventable causes of adverse pregnancy 
outcomes and focusing on smoking cessation should be a way to reduce the incidence of PTB.  
Despite a 20 to 40% reduction in smoking rates in pregnancy over the past 30 years10, between 11% 
and 13% of women continue to smoke throughout their pregnancy10-13. The introduction of anti-
smoking legislation has reduced PTB birth rates by around 10%14. This is most likely mediated by a 
reduction in the number of women smoking during their pregnancies, but there is emerging 
evidence that environmental exposure to tobacco smoke, known as passive smoking, may also affect 
PTB rates. It has been estimated that 11-50% of non-smoking pregnant women are exposed to 
environmental tobacco smoke5,7,15-17 and this exposure has been associated with reduced birth 
weight5.  
Currently there is conflicting evidence on the effects of ETSE (environmental tobacco smoke 
exposure) on PTB. Several meta-analyses5-7 have failed to show an association between the two, but 
existing studies are limited by residual confounding factors and the difficulties of accurately 
determining exposure. In this paper we have addressed these limitations by designing a study with 
correction for confounding factors and by evaluating the use of a recently introduced routine 
measure of exposure in the first trimester, namely exhaled carbon monoxide (eCO) levels. The levels 
of eCO  have been shown to correlate with the number of cigarettes smoked18 and are affected by 
ETSE19-21.  The objective of this study was to investigate whether ETSE is an independent risk factor 
for shortened gestation and preterm birth, using both self-report and eCO, as an objective measure 
of exposure, in a large obstetric population.   
Methods 
Study design and sample 
We performed a retrospective cohort study of all women with singleton pregnancies of at least 
23 weeks gestation delivering at the University Hospitals Bristol NHS Foundation Trust between April 
2012 and September 2014.  Women were identified using the computerised Maternity Medway 
Database which records details of all women delivering within the Trust. At the first antenatal 
appointment, usually before 12 weeks gestation, the community midwife enters relevant obstetric 
and medical history into the database including the woman’s smoking status, eCO level, her 
partner’s smoking status and the presence of any other smokers in the household. Information 
about the birth is added to this computerised record immediately after delivery.  
Multiple births often have obstetric complications that result in a higher incidence of preterm birth. 
The analysis was restricted to singleton births. Due to the referral nature of our hospital, women 
were referred from across the region for a variety of serious pregnancy complications. These ‘out-of-
area’ women had a higher background risk of preterm birth because of these complications and 
were excluded from the study population in order to improve the representativeness of the study. 
Ethical approval for this study was obtained from the University of Bristol Research Ethics 
Committee (ref. 2120).  
Outcomes 
The primary outcomes for this study were gestational age at delivery and preterm birth (<37 
weeks’ gestation). Gestational age at delivery (in weeks) was calculated from antenatal ultrasound 
scan (USS; usually during the first trimester), or last menstrual period where USS had not taken 
place. Secondary outcomes included birth weight and small-for-gestational age (defined as less than 
the population gestation-specific 10th centile).  
Exposures 
Exposure to environmental tobacco smoke was assessed in two ways. First, by self-report; a 
binary variable was created where pregnant women were coded as exposed if they reported that 
either their partner or another member of the household smoked. We refer to this as ‘household 
smoking’. Second, by objective measurement; exhaled CO was measured at the first antenatal 
appointment (usually during the first trimester) using a hand-held Bedfont piCO+ Smokerlyzer 
(Bedfont Scientific, UK, http://www.bedfont.com). Women were asked to inhale and hold their 
breath for 15 seconds before exhaling into the analyser. The first reading was recorded.  
Potential confounders 
We assessed several potential confounders, identified from the literature and univariate 
analyses, in logistic regression models. These include maternal smoking, maternal age at delivery, 
body mass index (BMI = weight (kg) /height (m)2), fetal sex, parity, ethnicity, a diagnosis of asthma22 
or pre-eclampsia23, employment status, and socioeconomic position as determined by postcode-
linked Index of Multiple Deprivation scores which have been shown to be a useful marker of 
socioeconomic status24. Age at delivery, fetal sex and any current pregnancy diagnosis of pre-
eclampsia were recorded at delivery, whilst self-reported maternal smoking status and the other 
variables were recorded at the first antenatal appointment, usually in the first trimester.  
Analysis 
A range of summary statistics was used to describe the women in the study. We used z-tests and 
chi-squared tests to compare the characteristics of women in the analysis samples with those 
eligible but excluded from the analysis due to a missing value on one or more of the covariables.   
Analysis strategy and models 
To check the external validity of the hospital database, we first examined the associations 
between self-reported maternal smoking and each outcome to ensure they were comparable to 
previously reported estimates. Next we considered the effect of ETSE. Both self-reported household 
smoking and measured eCO were used as indicators of ETSE. Two analysis models were used: The 
first included all women and adjusted for maternal smoking. The second considered only the non-
smoking women. Both models were adjusted for maternal age, BMI, parity, ethnicity, employment 
status, socioeconomic position, asthma, pre-eclampsia and offspring sex.  
These models were fitted for each of the outcomes. Logistic regression was used for binary 
outcomes (preterm birth (PTB) and small for gestational age (SGA)) and linear regression for 
continuous outcomes (gestational age at delivery and birth weight). Likelihood ratio tests (for logistic 
regression models) and F-tests (for linear regression models) were used to test for any association 
between the exposures and outcomes. 
The eCO cut-off value at which exposure to environmental tobacco smoke can be determined is 
uncertain. Several authors have suggested cut off values between 2 ppm25 and 4 ppm26,27 when 
distinguishing smokers from non-smokers; a value of 2 ppm giving a sensitivity of 86% and specificity 
of 90%25. To examine whether our results were robust to the choice of cut off and way in which eCO 
was classified, we repeated the analysis using 4 ppm and 6 ppm as cut offs instead of 2ppm. We also 
modelled the relationship between eCO and the outcomes as a linear continuous variable, and as a 
shape-free cubic spline to see whether there was a particular form of relationship that was missed 
by our main parameterisation.  
STATA version 13.1 was used for all analyses. 
Results  
Sample description 
We documented 13359 eligible deliveries at gestations greater than 23 weeks, after excluding 
multiple pregnancies (450 deliveries) and one case with no gestational age at delivery recorded 
(Figure 1). For the analyses involving self-reported exposure there were 5066 deliveries (38%) with 
complete data and for the analyses involving objective exposure (eCO) there were 4793 cases (36%) 
with complete data.  
A comparison of the characteristics of the complete cases (see figure 1) and those eligible but 
with at least one piece of missing data is shown in Table 1. The median age was 30 years and the 
majority of women were white and employed. Approximately 42% of all women reported the 
presence of a smoker in their household and the median eCO was 1 ppm. The proportion of exposed 
non-smokers increased from 17.8%, when considering partner smoking alone, to 28.0% when 
considering all household members. In the analysis group, the incidence of preterm birth was 6.3%. 
This rate was slightly lower among those with missing information. Paradoxically, those missing 
some information on covariables, and therefore not included in the analysis, were more likely to 
report living with a smoker. Women reporting as non-smokers were more likely to have information 
on household smoking and eCO readings missing. The gestational age at booking was not 
significantly different between the exposed and unexposed women. 
Association of exposures and outcomes with confounders 
Generally, women from more deprived postal areas and women unemployed or unfit to work 
were more likely to live with smokers, have higher eCO readings, and a higher risk of preterm birth 
and SGA baby. The distributions of household smoking, eCO and outcomes were also patterned to a 
varying extent by the other potential confounders (maternal age, parity, BMI, ethnicity and asthma) 
(data not shown). Smoking was associated with a lower risk of pre-eclampsia (OR 0.68 95% CI 0.50 – 
0.93). 
Maternal smoking: Prevalence and association with perinatal outcomes 
Of the 13094 women whose smoking status was known, 2946 women reported smoking in the 
early part of their pregnancy (22.5%). Of these smokers, 1043 (35.4%) stopped before their first 
antenatal appointment, leaving 14.5% of women reporting as smokers at the first antenatal 
appointment.  
After adjustment for maternal age, BMI, ethnicity, parity, employment status, socioeconomic 
status, fetal sex, paternal smoking, pre-eclampsia and asthma, maternal smoking was associated 
with a more than two-fold increased risk of preterm birth (OR: 2.16; 95% CI 1.56 – 2.99, p<0.001), a 
reduction in gestational length of 0.6 weeks (95% CI -0.7 to -0.4, p<0.001), a mean reduction in birth 
weight of 350 g (CI -399 to -302, p<0.001), and a three times greater risk of SGA (OR 3.06, 95% CI 
2.33 – 4.03, p<0.001) when compared to non-smoking women. Compared to eCO readings of zero, 
eCO values ≥2 ppm were associated with an increased risk of preterm birth (OR 1.63, 95% CI 1.14-
2.32, p=0.017) and SGA (OR 1.76, 95% CI 1.34-2.32, p<0.001),  a shorter gestation (-0.29 weeks; 95% 
CI -0.45 to -0.12, p=0.003) and  a mean reduction in birth weight (-166 g; 95% CI -214 to -118 g, 
p<0.001). 
There was no evidence that women who stopped smoking between conception and their first 
antenatal appointment were at any additional risk of PTB, reduced gestational length, lower birth 
weight babies or SGA when compared to non-smokers.  
ETSE and perinatal outcomes 
Self-reported exposure  
After adjustment for maternal smoking, women who reported themselves as exposed to ETS 
gave birth to their babies earlier. These associations persisted when considering only the non-
smoking women and after adjustment for confounding factors including pre-eclampsia (Table 2); 
babies were born on average 0.19 weeks earlier (95% CI: -0.32 to -0.05) among non-smoking women 
that reported a smoker in the house compared with non-smokers with no household exposure.  
We found a crude association between self-reported exposure to household smoking and 
preterm birth: The odds of preterm birth were 31% higher (95% CI: 0 to 72%) among women living 
with smokers (after adjusting for maternal smoking), but this weakened to 22% (95% CI: -9 to 62%) 
after adjustment for other potential confounders, providing no evidence of an independent 
association between self-reported ETSE and preterm birth (Table 3).  
There was strong evidence that babies born to mothers who lived with smokers had lower birth 
weights when compared to the babies born to unexposed mothers, after adjustment for maternal 
smoking and other confounders (Table 4). This association remained consistent when considering 
only the non-smoking mothers. Babies born to non-smoking mothers who reported a smoker in their 
household were on average 56g lighter (95% CI: -97 to -16g).  
Self-reported ETSE was not associated with a change in the risk of SGA. (Table 5).  
Exhaled carbon monoxide measurement as an objective measure of ETSE  
When an eCO level greater than 2 ppm was used to define ETSE there was no association 
between ETSE and gestational age at delivery, preterm birth, birth weight or risk of SGA. This was 
the case when considering all women with adjustment for maternal smoking and when considering 
non-smoking women alone.   
Sensitivity analysis 
There is some controversy about the best value for eCO to define ETSE26,27. When replacing ≥2 
ppm with ≥4 ppm as a cut off category for eCO, as suggested elsewhere,26,27 there was some weak 
evidence of an association between preterm birth and eCO-measured ETSE. For example the odds 
ratio for preterm birth adjusting for maternal smoking and confounders was 1.7 (95% CI: 1.04 to 2.8) 
in all women and 2.04 (95% CI: 0.9 to 4.64) in non-smoking women. When ≥6 ppm was used as the 
cut-off for eCO-determined ETSE the associations were stronger than for 2 ppm although there was 
no statistical evidence of an association with preterm birth. The results for SGA were fairly 
consistent regardless of choice of cut-off. For gestational age and birth weight, the associations were 
generally stronger when a higher eCO cut-off was used, making the results more similar to those 
where ETSE was determined by self-report (results available on request). When eCO was treated as a 
linear continuous variable there was no evidence for an association between eCO-measured ETSE 
and preterm birth, SGA, birthweight or gestational age.  
Discussion 
This is the first large cohort study to consider the effect of ETSE on preterm birth and gestational 
age at delivery using eCO as an objective measure of exposure. When smoking women were 
included in the analysis, elevated eCO levels were strongly associated with preterm birth, reduced 
gestational age at delivery, reduced birth weight and increased risk of SGA. However when the 
smokers were excluded or controlled for, elevated eCO readings were not significantly associated 
with any of the outcome measures. Self-reported ETSE was strongly associated with reduced 
gestational age at delivery and reduced birth weight, but not with an increased risk of SGA or PTB.  
Strengths & Limitations 
This population-based study includes over 13000 women of which more than a third were non-
smoking women with complete information on their environmental smoke exposure. The proportion 
of women exposed to environmental tobacco smoke varies in the literature depending upon how 
exposure is defined, the country studied, and the time of the study, because smoking prevalence has 
changed over recent decades10. Traditional family structures and living circumstances have changed 
considerably over the last few decades. Whilst ETSE from work is now less common because of anti-
smoking legislation, women are still at risk of ETSE if their partner or any member of the household 
smokes.  Our study is strengthened by our use of a combined measure of exposure; simply 
considering the smoking status of a woman’s partner, as many studies have done, may be 
inadequate in assessing her exposure. We have shown that the proportion of exposed non-smokers 
increased from 17.8%, when considering partner smoking alone, to 28.0% when considering all 
household members.  
Self-reported smoking behaviour has generally been found to be reliable when it has been 
validated with biochemical measures28. However, some evidence suggests self-reporting of both 
active and passive smoking may be less reliable in pregnancy29-31, perhaps because of the additional 
social stigma associated with smoking in pregnancy and the desire to make a good impression to 
healthcare professionals. The use of an objective measure is a strength of our study. Many objective 
measures of exposure have been used previously; nicotine and cotinine, the major metabolite of 
nicotine32, can be measured in serum30, saliva33 hair31, meconium34 and urine27. Measuring eCO 
levels has the advantage of being cheap, non-invasive, and giving immediate results; eCO levels 
correlate well with other biochemical measures of exposure18,20. Whilst a number of studies have 
considered the role of eCO in determining a woman’s smoking status18,25,27,35,36, none have used eCO 
to define exposure when considering the effect of ETSE on gestational age at delivery.  A cut-off of 2 
ppm was chosen after recent data suggested specificity of 90% and sensitivity of 86% at this level 
when distinguishing between smokers and non-smokers25. Since asthma22 and pre-eclampsia37 have 
been reported to affect eCO levels, we ensured these confounders were included when adjusting 
the models.  
Whilst most studies have adjusted for possible confounding factors such as maternal age, parity, 
race and socioeconomic status2, adjustments for pre-eclampsia have not been made previously5. 
Pre-eclampsia is a common reason for elective preterm birth. Active maternal smoking appears to 
decrease the risk pre-eclampsia by approximately 30%23,38. A similar trend for passive smoking has 
been reported39. This complex interplay requires that pre-eclampsia is considered when determining 
the effect of smoking, active or passive, on preterm birth rates, in order to avoid under-estimating 
the true effect of smoking. The correction for pre-eclampsia as a confounding factor is another 
strength of our study and may explain the greater risk of preterm birth for smokers that we 
observed (OR 2.16) compared to the more conservative estimate in a recent meta-analysis (OR 
1.27)2. 
The prospective way in which exposure information was collected reduces the risk of reporting 
bias. However, the study is restricted by the large proportion of missing data, especially exposure 
information. Although women’s smoking status was well recorded (98%), their partner’s status and 
the presence of other smokers in the household were less frequently recorded (54% and 49% of 
cases respectively). Despite national recommendations in the UK that all women, regardless of their 
smoking status, have eCO readings taken at their first antenatal appointment40, readings were only 
recorded in 42% cases. Women with incomplete data were excluded from the analyses (figure 1) 
possibly introducing selection bias, although no consistent differences in associations were observed 
in this ‘missing data’ cohort and the analysis group, and there was no systematic reason for data not 
being available. 
Our objective measure of ETSE has its limitations: CO has a short half-life (around 1-4 hours)36 
and the time since exposure affects readings; eCO may not accurately represent exposure in some 
women. This and the considerable overlap in eCO readings for ETSE compared with active maternal 
smoking may have made it difficult to detect a relationship between ETSE (when defined by eCO 
readings) and perinatal outcomes.  The association observed between preterm birth and higher eCO 
levels (>4 ppm) could represent more heavily exposed non-smokers or perhaps smokers reporting as 
non-smokers.  
Seasonal variation in birth patterns including the outcomes considered here has been 
described41, although few studies on perinatal outcomes adjust for this. Additionally, seasonal 
variation in ETSE is possible, with women potentially more exposed at times of the year with poorer 
weather. Our data had insufficient information to make seasonal adjustments but we recommend 
further research on the effect of ETS consider these issues where possible.  
In this study smoking rates in pregnancy (14.5%) were similar to those previously reported in the 
literature (11-16%)10,12,16; interestingly the proportion of non-smoking women reporting exposure to 
ETS (28%) was more than twofold higher than recent reports for other UK and European populations 
(11-13%)7,16 and probably reflects the inclusion of women living with smokers as well as those whose 
partners smoke (most studies only consider exposure from partner smoking). It is also possible that 
the addition of an objective measure of exposure (eCO reading) may encourage disclosure or even 
some smokers to self-report as exposed non-smokers.   
Biochemical measures of exposure may alleviate some of the problems associated with 
inaccurate self-reporting. However, the use of biochemical measures is not without problems; 
differentiating between light active smokers and heavily-exposed passive smokers remains difficult42 
and adjustment for maternal smoking requires reliance on maternal reports of smoking behaviour. 
Whilst knowing the effects of lower levels of exposure is important (whether that is from 
environmental or lighter active smoking) the success of programmes aimed at changing smoking 
behaviour will depend upon knowing to whom interventions should be targeted. We recommend 
that biochemical measures of exposure are used in conjunction with self-reporting. 
Self-reported ETSE was strongly associated with reduced gestational age at delivery, a 
relationship which has previously been debated5,6. Although this mean reduction (0.2 weeks) is small 
at an individual level, at a population level this may shift the distribution to the left resulting in a 
significant burden; further, active maternal smoking only reduced gestation by 0.6 weeks on average 
and yet more than doubled the rate of preterm birth. The deleterious effect of ETSE on perinatal 
outcomes is also emphasised by the finding of a strong association with reduced birth weight of a 
similar magnitude to that previously reported5,6,16. Our study shows that ETSE is associated with both 
shorter gestation and reduced birth weight, but it was not associated with an increased risk of either 
SGA or PTB. A larger number of participants may be required to study the associations of ETSE with 
non-continuous, rarer outcomes such as preterm birth and SGA. 
Conclusions 
Pregnant women reporting household exposure to environmental tobacco smoke deliver their 
babies at earlier gestations and with lower birth weights when compared to unexposed women. The 
value of eCO as an objective measure of exposure and in quantifying the risk of adverse perinatal 
outcomes remains to be determined. This information is important in advising women and their 
families and further supports public health efforts to reduce exposure to tobacco smoke.  
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Figure 1. Participant flow chart and derivation of the analysis sample. 
  
Table 1. A comparison of the characteristics of the cases included in the analysis sample for self-reported ETSE and others who were eligible but excluded 
due to missing data. 
 SELF-REPORTED EXPOSURE  eCO-MEASURED EXPOSURE 
  
Included in analysis 
sample 
(n=5066) 
Excluded from analysis due to one 
or more missing variables 
Included in analysis 
sample 
(n=4793) 
Excluded from analysis due to one 
or more missing variables 
Variable N (%) or median (IQR) N (%) or median (IQR) 
No. of cases 
with data 
available 
N (%) or median (IQR) N (%) or median (IQR) 
No. of cases 
with data 
available 
Age (y) 30 (26, 34) 30 (26, 34) 8133 30 (26, 34) 30 (26, 34) 8409 
BMI (kg/m2) 24.4 (21.7, 28.3) 24.4 (21.8, 28.2) 7568 24.4 (21.8, 28.4) 24.4 (21.8, 28.1) 7843 
Parity        
0 2210 (43.6) 3727 (45.7) 
8165 
2071 (43.2) 3866 (45.8) 
8438 1 1750 (34.5) 2650 (32.5) 1613 (33.7) 2787 (33.0) 
≥2 1106 (21.8) 1788 (21.9) 1109 (23.1) 1785 (21.2) 
Ethnicity       
White 4179 (82.5) 6020 (81.4) 
7392 
3924 (81.9) 6275 (81.9) 
7665 
Afro-Caribbean 333 (6.6) 595 (8.1) 332 (6.9) 596 (7.8) 
Asian 333 (6.6) 484 (6.6) 311 (6.5) 506 (6.6) 
Mixed 147 (2.9) 205 (2.8) 161 (3.4) 191 (2.5) 
Other 74 (1.5) 88 (1.2) 65 (1.4) 97 (1.3) 
Employment status       
Employed 3258 (64.3) 3160 (66.5) 
4749 
3073 (64.1) 3345 (66.6) 
5022 
Unemployed 1644 (32.5) 1453 (30.6) 1567 (32.7) 1530 (30.5) 
In education 128 (2.5) 117 (2.5) 122 (2.6) 123 (2.5) 
Medically unable to work 36 (0.7) 19 (0.4) 31 (0.7) 24 (0.5) 
Deprivation score (/100)‡ 24.8 (13.9, 43.3) 21.8 (12.5, 38.9) 8106 25.2 (13.7, 47.4) 21.6 (12.5, 36.8) 8379 
Asthma 460 (9.1) 617 (7.4) 8293 450 (9.4) 627 (7.3) 8566 
Pre-eclampsia 197 (3.9) 247 (3.0) 8293 168 (3.5) 276 (3.2) 8566 
Booking gestational age 
(weeks) 
10.1 (9, 11.3) 10.1 (9, 11.9) 7484 10.1 (9, 11.9) 10.1 (9, 11.9)  7796 
Offspring sex (female) 2495 (49.3) 4050 (48.9) 8286 2365 (49.3) 4180 (48.8) 8559 
Smoking during 
pregnancy 
      
Non-smoker 3661 (72.3) 6487 (80.8) 
8028 
3484 (72.7) 6664 (80.3) 
8301 Smoker 889 (17.6) 1014 (12.6) 845 (17.6) 1058 (12.8) 
Quit after conception 516 (10.2) 527 (6.6) 464 (9.7) 579 (7.0) 
Household smokers 2122 (41.9) 411 (50.1) 821 1449 (42.1) 1084 (44.4) 2445 
eCO (ppm)       
0   
 
2022 (42.2) 370 (46.5) 
795 
0 to 2   1569 (32.7) 211 (26.5) 
>2   1202 (25.1) 214 (26.9) 
Median (IQR)   1 (0, 2.6) 1 (0, 3) 
Preterm 319 (6.3) 478 (5.8) 8293 300 (6.3) 497 (5.8) 8566 
Gestational age (weeks) 40 (39, 40.9) 40 (39, 41) 8293 40 (39, 40.9) 40.1 (39, 41) 8566 
SGA  537 (10.6) 796 (9.6) 8284 513 (10.7) 820 (9.6)  
Birth weight (kg) 3.41 (3.06, 3.74) 3.43 (3.10, 3.76) 8290 3.40 (3.06, 3.73) 3.43 (3.10, 3.76) 8563 
‡Index of Multiple Deprivation score (2007) 
Table 2. Association between gestational age at delivery and exposure to environmental tobacco smoke (as captured by self-report of household smokers 
(HH), and measured eCO). Regression coefficients were estimated in the whole sample and in the non-smoking women.   
 Crude* Adjusted† 
All women  Mean difference  
(95% CI) 
p Mean difference  
(95% CI) 
P 
HH smokers (n=5066) No Reference  Reference  
Yes -0.2 (-0.32, -0.07) 0.002 -0.15 (-0.28, -0.02) 0.020 
eCO (ppm) (n=4793) 0 Reference  Reference  
0 to 1.99 0.03 (-0.10, 0.16)  -0.01 (-0.15, 0.12)  
≥2 -0.10 (-0.29, 0.08) 0.39 -0.13 (-0.32, 0.06) 0.380 
Non-smoking women  
HH smokers (n=3661) No Reference  Reference  
Yes -0.21 (-0.34, -0.08) 0.001 -0.19 (-0.32, -0.05) 0.007 
eCO (ppm) (n=3484) 0 Reference  Reference  
0 to 1.99 0.01 (-0.12, 0.14)  -0.03 (-0.16, 0.11)  
≥2 -0.01 (-0.22, 0.20) 0.98 -0.07 (-0.28, 0.14)  0.8 
*adjusted for maternal smoking in the models using all women. †adjusted for maternal age, BMI, parity, ethnicity, employment status, socioeconomic position, asthma, 
pre-eclampsia plus maternal smoking in the models using all women 
 
Table 3. Association between preterm birth and exposure to environmental tobacco smoke (as captured by self-report of household smokers (HH), and 
measured eCO). Odds ratios were estimated in the whole sample and in the non-smoking women.   
 Crude* Adjusted† 
All women  OR (95% CI) p OR (95% CI) P 
HH smokers (n=5066) None Reference  Reference  
Yes 1.31 (1.0, 1.72) 0.05 1.22 (0.91, 1.62) 0.18 
eCO (ppm) (n=4793) 0 Reference  Reference  
0 to 1.99 1.00 (0.74, 1.36)  1.06 (0.78, 1.45)  
≥2 1.27 (0.86, 1.88)  0.40 1.36 (0.91, 2.03) 0.31 
Non-smoking women  
HH smokers (n=3661) None Reference  Reference  
Yes 1.20 (0.86, 1.66)  0.28 1.15 (0.81, 1.63) 0.43 
eCO (ppm) (n=3484) 0 Reference  Reference  
0 to 1.99 0.94 (0.68, 1.31)  0.99 (0.70, 1.40)  
≥2 1.18 (0.73, 1.92) 0.68 1.24 (0.75, 2.05) 0.80 
*adjusted for maternal smoking in the models using all women. †adjusted for maternal age, BMI, parity, ethnicity, employment status, socioeconomic position, asthma, 
pre-eclampsia plus maternal smoking in the models using all women 
 
  
Table 4. Association between birth weight and exposure to environmental tobacco smoke (as captured by self-report of household smokers (HH), and 
measured eCO). Regression coefficients were estimated in the whole sample and in the non-smoking women 
 Crude* Adjusted† 
All women  Mean difference 
(95% CI) 
p Mean difference 
(95% CI) 
P 
HH smokers (n=5066) None Reference  Reference  
 Yes -61 (-97, -24) 0.001 -49 (-86, -13) 0.008 
eCO (ppm) (n=4793) 0 Reference  Reference  
 0 to 1.99 47 (9, 86)  26 (-11, 64)   
 2+ -10 (-64, 44) 0.02 -28 (-80, 25) 0.095 
Non-smoking women      
HH smokers (n=3661) None Reference  Reference  
 Yes -56 (-96, -15) 0.007 -56 (-97, -16) 0.006 
eCO (ppm) (n=3484) 0 Reference  Reference  
 0 to 1.99 37 (-2, 77)  13 (-25, 52)  
 2+ 47 (-16, 110) 0.106 24 (-37, 85) 0.65 
*adjusted for maternal smoking in the models using all women. 
†adjusted for maternal age, BMI, parity, ethnicity, employment status, socioeconomic position, asthma, pre-eclampsia plus maternal smoking in the models using all 
women 
  
Table 5. Association between SGA and exposure to environmental tobacco smoke exposure (as captured by self-report of household smokers (HH), and 
measured eCO). Odds ratios were estimated in the whole sample and in the non-smoking women 
 Crude* Adjusted† 
All women  OR (95% CI) P OR (95% CI) P 
HH smokers (n=5066): None Reference  Reference  
 Yes 1.09 (0.88, 1.36) 0.42 1.10 (0.88, 1.39) 0.39 
eCO (ppm) (n=4793): 0 Reference  Reference  
 0 to 1.99 0.83 (0.66, 1.05)  0.89 (0.70, 1.13)  
 ≥2 0.98 (0.72, 1.33) 0.28 1.05 (0.76, 1.44) 0.46 
Non-smoking women      
HH smokers (n=3661): None Reference  Reference  
 Yes 1.01 (0.78, 1.32) 0.91 1.06 (0.80, 1.40) 0.7 
eCO (ppm) (n=3484): 0 Reference  Reference  
 0 to 1.99 0.92 (0.71, 1.18)  0.99 (0.76, 1.29)  
 ≥2 0.66 (0.42, 1.04) 0.19 0.70 (0.44, 1.29) 0.31 
*adjusted for maternal smoking in the models using all women. 
†adjusted for maternal age, BMI, parity, ethnicity, employment status, socioeconomic position, asthma, pre-eclampsia plus maternal smoking in the models using all 
women 
 
